FierceBiotech1d
Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision
As Cytokinetics’ aficamten awaits approval decisions from regulators in the U.S. and China, Sanofi has picked up China rights ...
STAT7d
Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug discount program
The 340B program has become a flash point in the growing debate over the cost of prescription drugs in the U.S.
Sanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMS
Sanofi ( (SNY) ) has issued an announcement.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked ...
Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, ...
Modern Healthcare4d
Sanofi sues feds over moves to stop 340B rebate proposal
Sanofi, Johnson & Johnson, Eli Lilly and Bristol Myers Squibb have each filed complaints after facing federal opposition to ...
FiercePharma2d
Sanofi and Regeneron's Dupixent, Leo Pharma's Anzupgo could help close treatment gap in chronic hand eczema: GlobalData
Sanofi and Regeneron are in the process of testing out blockbuster biologic Dupixent in the indication, for one, and ...
FierceBiotech4d
Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in midstage trial
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...
Sanofi to acquire rights to develop, commercialize aficamten from Corxel
Cytokinetics (CYTK) announced that Sanofi (SNY) will acquire exclusive rights to develop and commercialize aficamten from Corxel ...
Sanofi employees embrace spirit of giving, fulfilling wishes for families in need
It's a special delivery for Pocono Services for Families and Children at the Mountain Center in Tobyhanna. Bag after bag of ...
MM&M2d
Rx Rundown: Sanofi, Novartis, Roche and more
The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...
Presse release: Jean-Paul Kress to join Sanofi's Board of Directors
Jean-Paul Kress to join Sanofi's Board of DirectorsParis, December 19, 2024. Sanofi's Board of Directors is pleased to welcome Jean-Paul Kress as ...